National Institute of Allergy and Infectious Diseases; Notice of Meetings, 71438-71439 [2019-27858]
Download as PDF
<![CDATA[
71438
Federal Register / Vol. 84, No. 248 / Friday, December 27, 2019 / Notices
Review/DERA, National Heart, Lung, and
Blood Institute, 6701 Rockledge Drive, Room
7190, Bethesda, MD 20892–7924, 301–827–
7912, copeka@mail.nih.gov.
Name of Committee: Heart, Lung, and
Blood Initial Review Group; NHLBI
Mentored Patient-Oriented Research Review
Committee.
Date: February 27–28, 2020.
Time: 8:30 a.m. to 2:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: Embassy Suites at the Chevy Chase
Pavilion, 4300 Military Road NW,
Washington, DC 20015.
Contact Person: Stephanie Johnson Webb,
Ph.D., Scientific Review Officer, Office of
Scientific Review/DERA, National Heart,
Lung, and Blood Institute, 6701 Rockledge
Drive, Room 7196, Bethesda, MD 20892, 301–
827–7992, stephanie.webb@nih.gov.
(Catalogue of Federal Domestic Assistance
Program Nos. 93.233, National Center for
Sleep Disorders Research; 93.837, Heart and
Vascular Diseases Research; 93.838, Lung
Diseases Research; 93.839, Blood Diseases
and Resources Research, National Institutes
of Health, HHS)
Dated: December 19, 2019.
Ronald J. Livingston, Jr.,
Program Analyst, Office of Federal Advisory
Committee Policy.
[FR Doc. 2019–27855 Filed 12–26–19; 8:45 am]
BILLING CODE 4140–01–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
jbell on DSKJLSW7X2PROD with NOTICES
National Institute of Allergy and
Infectious Diseases; Notice of
Meetings
Pursuant to section 10(d) of the
Federal Advisory Committee Act, as
amended, notice is hereby given of
meetings of the National Advisory
Allergy and Infectious Diseases Council.
The meetings will be open to the
public as indicated below, with
attendance limited to space available.
Individuals who plan to attend and
need special assistance, such as sign
language interpretation or other
reasonable accommodations, should
notify the Contact Person listed below
in advance of the meeting.
The meetings will be closed to the
public in accordance with the
provisions set forth in sections
552b(c)(4) and 552b(c)(6), Title 5 U.S.C.,
as amended. The grant applications and
the discussions could disclose
confidential trade secrets or commercial
property such as patentable material,
and personal information concerning
individuals associated with the grant
applications, the disclosure of which
would constitute a clearly unwarranted
invasion of personal privacy.
VerDate Sep<11>2014
18:44 Dec 26, 2019
Jkt 250001
Name of Committee: National Advisory
Allergy and Infectious Diseases Council.
Date: January 27, 2020.
Open: 10:30 a.m. to 11:40 a.m.
Agenda: Report from the Institute Director.
Place: National Institutes of Health,
Natcher Building, Conference Rooms E1/E2,
45 Center Drive, Bethesda, MD 20892.
Closed: 11:40 a.m. to 12:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health,
Natcher Building, Conference Rooms E1/E2,
45 Center Drive, Bethesda, MD 20892.
Contact Person: Matthew J. Fenton, Ph.D.,
Director, Division of Extramural Activities,
National Institute of Allergy and Infectious
Diseases, 5601 Fishers Lane, Rm 4F50,
Bethesda, MD 20892, 301–496–7291,
fentonm@niaid.nih.gov.
Name of Committee: National Advisory
Allergy and Infectious Diseases Council;
Allergy, Immunology and Transplantation
Subcommittee.
Date: January 27, 2020.
Closed: 8:30 a.m. to 10:15 a.m.
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health,
Natcher Building, Conference Room D, 45
Center Drive, Bethesda, MD 20892.
Open: 1:00 p.m. to adjournment.
Agenda: Reports from the Division Director
and other staff.
Place: National Institutes of Health,
Natcher Building, Conference Room D, 45
Center Drive, Bethesda, MD 20892.
Contact Person: Matthew J. Fenton, Ph.D.,
Director, Division of Extramural Activities,
National Institute of Allergy and Infectious
Diseases, 5601 Fishers Lane, Rm. 4F50,
Bethesda, MD 20892, 301–496–7291,
fentonm@niaid.nih.gov.
Name of Committee: National Advisory
Allergy and Infectious Diseases Council;
Microbiology and Infectious Diseases
Subcommittee.
Date: January 27, 2020.
Closed: 8:30 a.m. to 10:15 a.m.
Agenda: To review and evaluate grant
applications
Place: National Institutes of Health,
Natcher Building, Conference Rooms F1/F2,
45 Center Drive, Bethesda, MD 20892.
Open: 1:00 p.m. to adjournment.
Agenda: Reports from the Division Director
and other staff.
Place: National Institutes of Health,
Natcher Building, Conference Rooms F1/F2,
45 Center Drive, Bethesda, MD 20892.
Contact Person: Matthew J. Fenton, Ph.D.,
Director, Division of Extramural Activities,
National Institute of Allergy and Infectious
Diseases, 5601 Fishers Lane, Rm. 4F50,
Bethesda, MD 20892, 301–496–7291,
fentonm@niaid.nih.gov.
Name of Committee: National Advisory
Allergy and Infectious Diseases Council;
Acquired Immunodeficiency Syndrome
Subcommittee.
Date: January 27, 2020.
Closed: 8:30 a.m. to 10:15 a.m.
Agenda: To review and evaluate grant
applications.
PO 00000
Frm 00091
Fmt 4703
Sfmt 4703
Place: National Institutes of Health,
Natcher Building, Conference Room A, 45
Center Drive, Bethesda, MD 20892.
Open: 1:00 p.m. to adjournment.
Agenda: Program advisory discussions and
reports from division staff.
Place: National Institutes of Health,
Natcher Building, Conference Rooms E1/E2,
45 Center Drive, Bethesda, MD 20892.
Contact Person: Matthew J. Fenton, Ph.D.,
Director, Division of Extramural Activities,
National Institute of Allergy and Infectious
Diseases, 5601 Fishers Lane, Rm. 4F50,
Bethesda, MD 20892, 301–496–7291,
fentonm@niaid.nih.gov.
Name of Committee: National Advisory
Allergy and Infectious Diseases Council;
Allergy, Immunology and Transplantation
Subcommittee.
Date: June 1, 2020.
Closed: 8:30 a.m. to 10:15 a.m.
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health,
Natcher Building, Conference Room D, 45
Center Drive, Bethesda, MD 20892.
Open: 1:00 p.m. to adjournment.
Agenda: Reports from the Division Director
and other staff.
Place: National Institutes of Health,
Natcher Building, Conference Room D, 45
Center Drive, Bethesda, MD 20892.
Contact Person: Matthew J. Fenton, Ph.D.,
Director, Division of Extramural Activities,
National Institute of Allergy and Infectious
Diseases, 5601 Fishers Lane, Rm. 4F50,
Bethesda, MD 20892, 301–496–7291,
fentonm@niaid.nih.gov.
Name of Committee: National Advisory
Allergy and Infectious Diseases Council;
Microbiology and Infectious Diseases
Subcommittee.
Date: June 1, 2020.
Closed: 8:30 a.m. to 10:15 a.m.
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health,
Natcher Building, Conference Rooms F1/F2,
45 Center Drive, Bethesda, MD 20892.
Open: 1:00 p.m. to adjournment.
Agenda: Reports from the Division Director
and other staff.
Place: National Institutes of Health,
Natcher Building, Conference Rooms F1/F2,
45 Center Drive, Bethesda, MD 20892.
Contact Person: Matthew J. Fenton, Ph.D.,
Director, Division of Extramural Activities,
National Institute of Allergy and Infectious
Diseases, 5601 Fishers Lane, Rm. 4F50,
Bethesda, MD 20892, 301–496–7291,
fentonm@niaid.nih.gov.
Name of Committee: National Advisory
Allergy and Infectious Diseases Council;
Acquired Immunodeficiency Syndrome
Subcommittee.
Date: June 1, 2020.
Closed: 8:30 a.m. to 10:15 a.m.
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health,
Natcher Building, Conference Room A, 45
Center Drive, Bethesda, MD 20892.
Open: 1:00 p.m. to adjournment.
Agenda: Program advisory discussions and
reports from division staff.
E:\FR\FM\27DEN1.SGM
27DEN1
Federal Register / Vol. 84, No. 248 / Friday, December 27, 2019 / Notices
jbell on DSKJLSW7X2PROD with NOTICES
Place: National Institutes of Health,
Natcher Building, Conference Rooms E1/E2,
45 Center Drive, Bethesda, MD 20892.
Contact Person: Matthew J. Fenton, Ph.D.,
Director, Division of Extramural Activities,
National Institute of Allergy and Infectious
Diseases, 5601 Fishers Lane, Rm. 4F50,
Bethesda, MD 20892, 301–496–7291,
fentonm@niaid.nih.gov.
Name of Committee: National Advisory
Allergy and Infectious Diseases Council.
Date: June 1, 2020.
Open: 10:30 a.m. to 11:40 a.m.
Agenda: Report from the Institute Director.
Place: National Institutes of Health,
Natcher Building, Conference Rooms E1/E2,
45 Center Drive, Bethesda, MD 20892.
Closed: 11:40 a.m. to 12:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health,
Natcher Building, Conference Rooms E1/E2,
45 Center Drive, Bethesda, MD 20892.
Contact Person: Matthew J. Fenton, Ph.D.,
Director, Division of Extramural Activities,
National Institute of Allergy and Infectious
Diseases, 5601 Fishers Lane, Rm. 4F50,
Bethesda, MD 20892, 301–496–7291,
fentonm@niaid.nih.gov.
Name of Committee: National Advisory
Allergy and Infectious Diseases Council;
Microbiology and Infectious Diseases
Subcommittee.
Date: September 14, 2020.
Closed: 8:30 a.m. to 10:15 a.m.
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health,
Natcher Building, Conference Rooms F1/F2,
45 Center Drive, Bethesda, MD 20892.
Open: 1:00 p.m. to adjournment.
Agenda: Reports from the Division Director
and other staff.
Place: National Institutes of Health,
Natcher Building, Conference Rooms F1/F2,
45 Center Drive, Bethesda, MD 20892.
Contact Person: Matthew J. Fenton, Ph.D.,
Director Division of Extramural Activities,
National Institute of Allergy and Infectious
Diseases, 5601 Fishers Lane, Rm 4F50,
Bethesda, MD 20892, 301–496–7291,
fentonm@niaid.nih.gov.
Name of Committee: National Advisory
Allergy and Infectious Diseases Council.
Date: September 14, 2020.
Open: 10:30 a.m. to 11:40 a.m.
Agenda: Report from the Institute Director.
Place: National Institutes of Health,
Natcher Building, Conference Rooms E1/E2,
45 Center Drive, Bethesda, MD 20892.
Closed: 11:40 a.m. to 12:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health,
Natcher Building, Conference Rooms E1/E2,
45 Center Drive, Bethesda, MD 20892.
Contact Person: Matthew J. Fenton, Ph.D.,
Director, Division of Extramural Activities,
National Institute of Allergy and Infectious
Diseases, 5601 Fishers Lane, Rm 4F50,
Bethesda, MD 20892, 301–496–7291,
fentonm@niaid.nih.gov.
Name of Committee: National Advisory
Allergy and Infectious Diseases Council;
Allergy, Immunology and Transplantation
Subcommittee.
VerDate Sep<11>2014
18:44 Dec 26, 2019
Jkt 250001
Date: September 14, 2020.
Closed: 8:30 a.m. to 10:15 a.m.
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health,
Natcher Building, Conference Room D, 45
Center Drive, Bethesda, MD 20892.
Open: 1:00 p.m. to adjournment.
Agenda: Reports from the Division Director
and other staff.
Place: National Institutes of Health,
Natcher Building, Conference Room D, 45
Center Drive, Bethesda, MD 20892.
Contact Person: Matthew J. Fenton, Ph.D.,
Director, Division of Extramural Activities,
National Institute of Allergy and Infectious
Diseases, 5601 Fishers Lane, Rm 4F50,
Bethesda, MD 20892, 301–496–7291,
fentonm@niaid.nih.gov.
Name of Committee: National Advisory
Allergy and Infectious Diseases Council;
Acquired Immunodeficiency Syndrome
Subcommittee.
Date: September 14, 2020.
Closed: 8:30 a.m. to 10:15 a.m.
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health,
Natcher Building, Conference Room A, 45
Center Drive, Bethesda, MD 20892.
Open: 1:00 p.m. to adjournment.
Agenda: Program advisory discussions and
reports from division staff.
Place: National Institutes of Health,
Natcher Building, Conference Rooms E1/E2,
45 Center Drive, Bethesda, MD 20892.
Contact Person: Matthew J. Fenton, Ph.D.,
Director, Division of Extramural Activities,
National Institute of Allergy and Infectious
Diseases, 5601 Fishers Lane, Rm 4F50,
Bethesda, MD 20892, 301–496–7291,
fentonm@niaid.nih.gov.
In the interest of security, NIH has
instituted stringent procedures for entrance
onto the NIH campus. All visitor vehicles,
including taxicabs, hotel, and airport shuttles
will be inspected before being allowed on
campus. Visitors will be asked to show one
form of identification (for example, a
government-issued photo ID, driver’s license,
or passport) and to state the purpose of their
visit.
Information is also available on the
Institute’s/Center’s home page:
www.niaid.nih.gov/facts/facts.htm, where an
agenda and any additional information for
the meeting will be posted when available.
(Catalogue of Federal Domestic Assistance
Program Nos. 93.855, Allergy, Immunology,
and Transplantation Research; 93.856,
Microbiology and Infectious Diseases
Research, National Institutes of Health, HHS)
Dated: December 19, 2019.
Tyeshia M. Roberson,
Program Analyst, Office of Federal Advisory
Committee Policy.
[FR Doc. 2019–27858 Filed 12–26–19; 8:45 am]
BILLING CODE 4140–01–P
PO 00000
Frm 00092
Fmt 4703
Sfmt 4703
71439
DEPARTMENT OF HOMELAND
SECURITY
Coast Guard
[Docket No. USCG–2009–0973]
Random Drug Testing Rate for
Covered Crewmembers for 2020
Coast Guard, DHS.
Notice of minimum random
drug testing rate.
AGENCY:
ACTION:
The Coast Guard has set the
calendar year 2020 minimum random
drug testing rate at 50 percent of
covered crewmembers.
DATES: The minimum random drug
testing rate is effective January 1, 2020
through December 31, 2020.
FOR FURTHER INFORMATION CONTACT: For
questions about this notice, please
contact Mr. Patrick Mannion, Drug and
Alcohol Prevention and Investigation
Program Manager, Office of
Investigations and Analysis (CG–INV),
U.S. Coast Guard Headquarters, via
email; DAPI@uscg.mil.
SUPPLEMENTARY INFORMATION: The Coast
Guard requires marine employers to
establish random drug testing programs
for covered crewmembers in accordance
with 46 CFR 16.230. Marine employers
are required by 46 CFR 16.500 to collect
and maintain a record of drug testing
data for each calendar year, and submit
this data to the Coast Guard in a
Management Information System (MIS)
Report by March 15 of the following
year.
Each year, the Coast Guard will
publish a notice reporting the results of
random drug testing for the previous
calendar year’s MIS data and the
required minimum annual percentage
rate for random drug testing for the next
calendar year. The purpose of setting a
minimum random drug testing rate is to
promote maritime safety by establishing
an effective deterrent to drug misuse
within the maritime workforce.
Intoxicated operations poses a serious
threat to life, property and the
environment in the maritime commons.
As such, the minimum random drug
testing rate is intended to deter and
detect illegal drug misuse in the
maritime industry.
The Coast Guard announces that the
minimum random drug testing rate for
calendar year 2020 is 50 percent. The
Coast Guard continues a 50 percent
minimum random drug testing rate for
2020 as a result of MIS data for the most
recent reporting year which indicated
that the positive rate continues to be
greater than one percent. 46 CFR
16.230(f)(2) requires the Commandant to
SUMMARY:
E:\FR\FM\27DEN1.SGM
27DEN1
]]>Agencies
[Federal Register Volume 84, Number 248 (Friday, December 27, 2019)]
[Notices]
[Pages 71438-71439]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2019-27858]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
National Institutes of Health
National Institute of Allergy and Infectious Diseases; Notice of
Meetings
Pursuant to section 10(d) of the Federal Advisory Committee Act, as
amended, notice is hereby given of meetings of the National Advisory
Allergy and Infectious Diseases Council.
The meetings will be open to the public as indicated below, with
attendance limited to space available. Individuals who plan to attend
and need special assistance, such as sign language interpretation or
other reasonable accommodations, should notify the Contact Person
listed below in advance of the meeting.
The meetings will be closed to the public in accordance with the
provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5
U.S.C., as amended. The grant applications and the discussions could
disclose confidential trade secrets or commercial property such as
patentable material, and personal information concerning individuals
associated with the grant applications, the disclosure of which would
constitute a clearly unwarranted invasion of personal privacy.
Name of Committee: National Advisory Allergy and Infectious
Diseases Council.
Date: January 27, 2020.
Open: 10:30 a.m. to 11:40 a.m.
Agenda: Report from the Institute Director.
Place: National Institutes of Health, Natcher Building,
Conference Rooms E1/E2, 45 Center Drive, Bethesda, MD 20892.
Closed: 11:40 a.m. to 12:00 p.m.
Agenda: To review and evaluate grant applications.
Place: National Institutes of Health, Natcher Building,
Conference Rooms E1/E2, 45 Center Drive, Bethesda, MD 20892.
Contact Person: Matthew J. Fenton, Ph.D., Director, Division of
Extramural Activities, National Institute of Allergy and Infectious
Diseases, 5601 Fishers Lane, Rm 4F50, Bethesda, MD 20892, 301-496-
7291, [email protected].
Name of Committee: National Advisory Allergy and Infectious
Diseases Council; Allergy, Immunology and Transplantation
Subcommittee.
Date: January 27, 2020.
Closed: 8:30 a.m. to 10:15 a.m.
Agenda: To review and evaluate grant applications.
Place: National Institutes of Health, Natcher Building,
Conference Room D, 45 Center Drive, Bethesda, MD 20892.
Open: 1:00 p.m. to adjournment.
Agenda: Reports from the Division Director and other staff.
Place: National Institutes of Health, Natcher Building,
Conference Room D, 45 Center Drive, Bethesda, MD 20892.
Contact Person: Matthew J. Fenton, Ph.D., Director, Division of
Extramural Activities, National Institute of Allergy and Infectious
Diseases, 5601 Fishers Lane, Rm. 4F50, Bethesda, MD 20892, 301-496-
7291, [email protected].
Name of Committee: National Advisory Allergy and Infectious
Diseases Council; Microbiology and Infectious Diseases Subcommittee.
Date: January 27, 2020.
Closed: 8:30 a.m. to 10:15 a.m.
Agenda: To review and evaluate grant applications
Place: National Institutes of Health, Natcher Building,
Conference Rooms F1/F2, 45 Center Drive, Bethesda, MD 20892.
Open: 1:00 p.m. to adjournment.
Agenda: Reports from the Division Director and other staff.
Place: National Institutes of Health, Natcher Building,
Conference Rooms F1/F2, 45 Center Drive, Bethesda, MD 20892.
Contact Person: Matthew J. Fenton, Ph.D., Director, Division of
Extramural Activities, National Institute of Allergy and Infectious
Diseases, 5601 Fishers Lane, Rm. 4F50, Bethesda, MD 20892, 301-496-
7291, [email protected]ih.gov.
Name of Committee: National Advisory Allergy and Infectious
Diseases Council; Acquired Immunodeficiency Syndrome Subcommittee.
Date: January 27, 2020.
Closed: 8:30 a.m. to 10:15 a.m.
Agenda: To review and evaluate grant applications.
Place: National Institutes of Health, Natcher Building,
Conference Room A, 45 Center Drive, Bethesda, MD 20892.
Open: 1:00 p.m. to adjournment.
Agenda: Program advisory discussions and reports from division
staff.
Place: National Institutes of Health, Natcher Building,
Conference Rooms E1/E2, 45 Center Drive, Bethesda, MD 20892.
Contact Person: Matthew J. Fenton, Ph.D., Director, Division of
Extramural Activities, National Institute of Allergy and Infectious
Diseases, 5601 Fishers Lane, Rm. 4F50, Bethesda, MD 20892, 301-496-
7291, [email protected].
Name of Committee: National Advisory Allergy and Infectious
Diseases Council; Allergy, Immunology and Transplantation
Subcommittee.
Date: June 1, 2020.
Closed: 8:30 a.m. to 10:15 a.m.
Agenda: To review and evaluate grant applications.
Place: National Institutes of Health, Natcher Building,
Conference Room D, 45 Center Drive, Bethesda, MD 20892.
Open: 1:00 p.m. to adjournment.
Agenda: Reports from the Division Director and other staff.
Place: National Institutes of Health, Natcher Building,
Conference Room D, 45 Center Drive, Bethesda, MD 20892.
Contact Person: Matthew J. Fenton, Ph.D., Director, Division of
Extramural Activities, National Institute of Allergy and Infectious
Diseases, 5601 Fishers Lane, Rm. 4F50, Bethesda, MD 20892, 301-496-
7291, [email protected].
Name of Committee: National Advisory Allergy and Infectious
Diseases Council; Microbiology and Infectious Diseases Subcommittee.
Date: June 1, 2020.
Closed: 8:30 a.m. to 10:15 a.m.
Agenda: To review and evaluate grant applications.
Place: National Institutes of Health, Natcher Building,
Conference Rooms F1/F2, 45 Center Drive, Bethesda, MD 20892.
Open: 1:00 p.m. to adjournment.
Agenda: Reports from the Division Director and other staff.
Place: National Institutes of Health, Natcher Building,
Conference Rooms F1/F2, 45 Center Drive, Bethesda, MD 20892.
Contact Person: Matthew J. Fenton, Ph.D., Director, Division of
Extramural Activities, National Institute of Allergy and Infectious
Diseases, 5601 Fishers Lane, Rm. 4F50, Bethesda, MD 20892, 301-496-
7291, [email protected].
Name of Committee: National Advisory Allergy and Infectious
Diseases Council; Acquired Immunodeficiency Syndrome Subcommittee.
Date: June 1, 2020.
Closed: 8:30 a.m. to 10:15 a.m.
Agenda: To review and evaluate grant applications.
Place: National Institutes of Health, Natcher Building,
Conference Room A, 45 Center Drive, Bethesda, MD 20892.
Open: 1:00 p.m. to adjournment.
Agenda: Program advisory discussions and reports from division
staff.
[[Page 71439]]
Place: National Institutes of Health, Natcher Building,
Conference Rooms E1/E2, 45 Center Drive, Bethesda, MD 20892.
Contact Person: Matthew J. Fenton, Ph.D., Director, Division of
Extramural Activities, National Institute of Allergy and Infectious
Diseases, 5601 Fishers Lane, Rm. 4F50, Bethesda, MD 20892, 301-496-
7291, [email protected].
Name of Committee: National Advisory Allergy and Infectious
Diseases Council.
Date: June 1, 2020.
Open: 10:30 a.m. to 11:40 a.m.
Agenda: Report from the Institute Director.
Place: National Institutes of Health, Natcher Building,
Conference Rooms E1/E2, 45 Center Drive, Bethesda, MD 20892.
Closed: 11:40 a.m. to 12:00 p.m.
Agenda: To review and evaluate grant applications.
Place: National Institutes of Health, Natcher Building,
Conference Rooms E1/E2, 45 Center Drive, Bethesda, MD 20892.
Contact Person: Matthew J. Fenton, Ph.D., Director, Division of
Extramural Activities, National Institute of Allergy and Infectious
Diseases, 5601 Fishers Lane, Rm. 4F50, Bethesda, MD 20892, 301-496-
7291, [email protected].
Name of Committee: National Advisory Allergy and Infectious
Diseases Council; Microbiology and Infectious Diseases Subcommittee.
Date: September 14, 2020.
Closed: 8:30 a.m. to 10:15 a.m.
Agenda: To review and evaluate grant applications.
Place: National Institutes of Health, Natcher Building,
Conference Rooms F1/F2, 45 Center Drive, Bethesda, MD 20892.
Open: 1:00 p.m. to adjournment.
Agenda: Reports from the Division Director and other staff.
Place: National Institutes of Health, Natcher Building,
Conference Rooms F1/F2, 45 Center Drive, Bethesda, MD 20892.
Contact Person: Matthew J. Fenton, Ph.D., Director Division of
Extramural Activities, National Institute of Allergy and Infectious
Diseases, 5601 Fishers Lane, Rm 4F50, Bethesda, MD 20892, 301-496-
7291, [email protected].
Name of Committee: National Advisory Allergy and Infectious
Diseases Council.
Date: September 14, 2020.
Open: 10:30 a.m. to 11:40 a.m.
Agenda: Report from the Institute Director.
Place: National Institutes of Health, Natcher Building,
Conference Rooms E1/E2, 45 Center Drive, Bethesda, MD 20892.
Closed: 11:40 a.m. to 12:00 p.m.
Agenda: To review and evaluate grant applications.
Place: National Institutes of Health, Natcher Building,
Conference Rooms E1/E2, 45 Center Drive, Bethesda, MD 20892.
Contact Person: Matthew J. Fenton, Ph.D., Director, Division of
Extramural Activities, National Institute of Allergy and Infectious
Diseases, 5601 Fishers Lane, Rm 4F50, Bethesda, MD 20892, 301-496-
7291, [email protected].
Name of Committee: National Advisory Allergy and Infectious
Diseases Council; Allergy, Immunology and Transplantation
Subcommittee.
Date: September 14, 2020.
Closed: 8:30 a.m. to 10:15 a.m.
Agenda: To review and evaluate grant applications.
Place: National Institutes of Health, Natcher Building,
Conference Room D, 45 Center Drive, Bethesda, MD 20892.
Open: 1:00 p.m. to adjournment.
Agenda: Reports from the Division Director and other staff.
Place: National Institutes of Health, Natcher Building,
Conference Room D, 45 Center Drive, Bethesda, MD 20892.
Contact Person: Matthew J. Fenton, Ph.D., Director, Division of
Extramural Activities, National Institute of Allergy and Infectious
Diseases, 5601 Fishers Lane, Rm 4F50, Bethesda, MD 20892, 301-496-
7291, [email protected].
Name of Committee: National Advisory Allergy and Infectious
Diseases Council; Acquired Immunodeficiency Syndrome Subcommittee.
Date: September 14, 2020.
Closed: 8:30 a.m. to 10:15 a.m.
Agenda: To review and evaluate grant applications.
Place: National Institutes of Health, Natcher Building,
Conference Room A, 45 Center Drive, Bethesda, MD 20892.
Open: 1:00 p.m. to adjournment.
Agenda: Program advisory discussions and reports from division
staff.
Place: National Institutes of Health, Natcher Building,
Conference Rooms E1/E2, 45 Center Drive, Bethesda, MD 20892.
Contact Person: Matthew J. Fenton, Ph.D., Director, Division of
Extramural Activities, National Institute of Allergy and Infectious
Diseases, 5601 Fishers Lane, Rm 4F50, Bethesda, MD 20892, 301-496-
7291, [email protected].
In the interest of security, NIH has instituted stringent
procedures for entrance onto the NIH campus. All visitor vehicles,
including taxicabs, hotel, and airport shuttles will be inspected
before being allowed on campus. Visitors will be asked to show one
form of identification (for example, a government-issued photo ID,
driver's license, or passport) and to state the purpose of their
visit.
Information is also available on the Institute's/Center's home
page: www.niaid.nih.gov/facts/facts.htm, where an agenda and any
additional information for the meeting will be posted when
available.
(Catalogue of Federal Domestic Assistance Program Nos. 93.855,
Allergy, Immunology, and Transplantation Research; 93.856,
Microbiology and Infectious Diseases Research, National Institutes
of Health, HHS)
Dated: December 19, 2019.
Tyeshia M. Roberson,
Program Analyst, Office of Federal Advisory Committee Policy.
[FR Doc. 2019-27858 Filed 12-26-19; 8:45 am]
BILLING CODE 4140-01-P
